Skip to main content

Equillium, Inc.

For the period ended Dec 31, 2025. Filed Mar 25, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 25, 2026

EQ$1.46-3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

(In thousands)

Year EndedDecember 31, · Year EndedDecember 31,
2025 · 2024
Operating activities:
Net loss$(22,398)$(8,067)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation116137
Loss on disposal of property and equipment19-
Stock-based compensation2,3223,750
Net unrealized (gain) loss on foreign currency transactions(474)794
Amortization of investments, net(14)(754)
Deferred revenue-(15,728)
Changes in operating assets and liabilities:
Accounts receivable-3,735
Prepaid expenses and other current assets1,2632,275
Accounts payable(1,937)(1,995)
Accrued expenses(1,685)(3,164)
Right-of-use assets and lease liabilities, net42(9)
Net cash used in operating activities(22,746)(19,026)
Investing activities:
Purchases of property and equipment(48)(85)
Proceeds from disposal of property and equipment12-
Purchases of short-term investments-(17,601)
Maturities of short-term investments4,50031,500
Net cash provided by investing activities4,46413,814
Financing activities:
Proceeds from a private placement of common stock and pre-funded warrants, net of issuance costs27,909-
Proceeds from exercise of stock options1,8364
Proceeds from issuance of common stock under ATM facility, net of issuance costs682-
Proceeds from issuance of common stock under employee stock purchase plan-160
Net cash provided by financing activities30,427164
Effect of exchange rate changes on cash and cash equivalents47(83)
Net increase (decrease) in cash and cash equivalents12,192(5,131)
Cash and cash equivalents at beginning of period18,08523,216
Cash and cash equivalents at end of period$30,277$18,085
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations$548$-
ATM facility issuance costs reclassed from other current assets$392$-
Exercise of stock options issuance costs in accounts payable$5$-
Supplemental cash flow information:
Cash paid for income taxes, net of refunds$352$-
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.